Status:

COMPLETED

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Lead Sponsor:

Medeor Therapeutics, Inc.

Collaborating Sponsors:

California Institute for Regenerative Medicine (CIRM)

Conditions:

Kidney Transplant Rejection

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antig...

Detailed Description

Currently, patients receiving a transplanted kidney are required to take life-long immunosuppressive medications to prevent rejection of the transplanted kidney. These medications carry substantial si...

Eligibility Criteria

Inclusion

  • Recipient
  • Planned recipient of a first kidney allograft from an HLA-matched, living related donor
  • Age ≥18 and ≤70 years
  • Single solid organ recipient (kidney only)
  • ABO matched with donor
  • Recipient

Exclusion

  • Underlying kidney disease with a high risk of disease recurrence in the transplanted kidney
  • Baseline positive donor-specific anti-HLA antibody testing
  • Is taking immunosuppressive therapy
  • Evidence of prior hepatitis B (HBV) or hepatitis C (HCV)
  • Donor Inclusion Criteria:
  • HLA-matched first degree (parent, child or sibling) or second-degree (child of a sibling or half sibling) relative of the prospective recipient participant
  • Age ≥18 and ≤70 years
  • Prepared to be a living related kidney donor, and capable of undergoing G-CSF mobilization and apheresis of hematopoietic cells
  • Donor

Key Trial Info

Start Date :

March 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 11 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03363945

Start Date

March 15 2018

End Date

April 11 2024

Last Update

June 7 2024

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

Loma Linda University Medical Center

Loma Linda, California, United States, 92354

2

USC

Los Angeles, California, United States, 90033

3

Stanford University Medical Center

Stanford, California, United States, 94305

4

University of Colorado Denver

Aurora, Colorado, United States, 80045

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants | DecenTrialz